Arcus Biosciences (RCUS) Operating Margin (QoQ) (2017 - 2026)
Arcus Biosciences (RCUS) Operating Margin (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Arcus Biosciences | 3.74 Bn | 3.04 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 55,409.00 |
| Mar 31, 2026 | -44,278.00 |
| Dec 31, 2025 | 20,070.00 |
| Sep 30, 2025 | -54,115.00 |
| Jun 30, 2025 | 43,071.00 |
| Mar 31, 2025 | -3,956.00 |
| Dec 31, 2024 | -17,740.00 |
| Sep 30, 2024 | 5,304.00 |
| Jun 30, 2024 | -26,076.00 |
| Mar 31, 2024 | 63,897.00 |
| Dec 31, 2023 | -40,000.00 |
| Sep 30, 2023 | 3,621.00 |
| Jun 30, 2023 | 5,779.00 |
| Mar 31, 2023 | -12,635.00 |
| Dec 31, 2022 | -553.00 |
| Sep 30, 2022 | 4,343.00 |
| Jun 30, 2022 | 11,667.00 |
| Mar 31, 2022 | -45,147.00 |
| Dec 31, 2021 | 90,512.00 |
| Sep 30, 2021 | -2,114.00 |